ESR2 and neoplasm: Seven (58%) and 5 (42%) ERβ+ patients were characterized by tumor grade 1 and 2 respectively, whereas the grades of 15 (47%), 13 (41%), and 3 (9%) ERβ− samples were 1, 2, and 3 respectively.